New York Times Examines FDA's Tentative Approval Of Aurobindo's Three-Drug Combination Antiretroviral Treatment For PEPFAR

... The New York Times on Thursday examined FDA's tentative approval of Indian drug manufacturer Aurobindo Pharma's generic medication that combines the antiretroviral drugs lamivudine, zidovudine and nevirapine (McNeil, New York Times, 7/6). FDA on Friday granted tentative approval to Aurobindo, which means the drug meets FDA safety and efficacy standards but cannot be sold in the U.S. [click link for full article] ...